Fees and funding

Open-access publishing is not without costs. Hereditary Cancer in Clinical Practice therefore levies an article-processing charge of £1790.00/$2490.00/€2090.00 for each article accepted for publication, plus VAT or local taxes where applicable. The APC is determined at the date of acceptance.

If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.

Springer Nature offers agreements that enable institutions to cover open-access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.

For more information on APCs please see our Journal Pricing FAQs

As a way to say thank you to the dedicated researchers who tirelessly work to advance the science and ultimately to improve the lives of the cancer genetics community, the journal is pleased to offer a 50% waiver on the article processing charges for select manuscripts published in Hereditary Cancer in Clinical Practice.

Before submitting your manuscript, and to receive editorial approval for the discount, please email the abstract of your manuscript to the Publishing Editor.